Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...
Sponsors who do not have an initial pediatric study plan (iPSP) or pediatric investigation plan (EU-PIP) can participate in the policy pilot by including a Canadian pediatric development plan (C-PDP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results